Topical Ranibizumab as a Treatment of Corneal Neovascularization
- 1 July 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Cornea
- Vol. 32 (7), 992-997
- https://doi.org/10.1097/ico.0b013e3182775f8d
Abstract
Purpose: To examine the effect of topical ranibizumab on clinically stable corneal neovascularization (NV). Methods: This was a prospective, open-label, monocentric, uncontrolled noncomparative study. Ten eyes of 9 patients with corneal NV received topical ranibizumab (1%) 4 times a day for 3 weeks with a follow-up period of 16 weeks. The main corneal NV outcome measures were: neovascular area, the area occupied by the corneal neovessels; vessel caliber (VC), the mean diameter of the corneal neovessels; and invasion area (IA), the fraction of the total cornea area covered by the vessels. This study was conducted at the Massachusetts Eye and Ear Infirmary, Boston, MA. Results: Statistically significant decreases in neovascular area (55.3%, P < 0.001), which lasted through 16 weeks, and VC (59%, P < 0.001), which continued to improve up to week 16, were observed after treatment. No significant decrease was observed in IA (12.3%, P = 0.49). There was no statistically significant change in visual acuity or intraocular pressure. No adverse events ascribed to the treatment were noted. Conclusions: Topical application of ranibizumab is effective in reducing the severity of corneal NV in the context of established corneal NV, mostly through decrease in VC rather than IA.Keywords
This publication has 33 references indexed in Scilit:
- Comparison of the effects of bevacizumab and ranibizumab injection on corneal angiogenesis in an alkali burn induced model2012
- Corneal Penetration of Topical and Subconjunctival BevacizumabInvestigative Ophthalmology & Visual Science, 2011
- The Impact of Subconjuctivally Injected EGF and VEGF Inhibitors on Experimental Corneal Neovascularization in Rat ModelCurrent Eye Research, 2011
- The Effect of Subconjunctival Ranibizumab on Primary Pterygium: A Pilot StudyCornea, 2010
- Treatment of inflamed pterygia or residual pterygial bedBritish Journal of Ophthalmology, 2009
- Subconjunctival ranibizumab for squamous cell carcinoma of the conjunctiva with corneal extensionBritish Journal of Ophthalmology, 2009
- The Effect of Topical Bevacizumab on Corneal NeovascularizationOphthalmology, 2008
- Corneal neovascularizationCurrent Opinion in Opthalmology, 2001
- Risk Factors for Corneal Graft Failure and Rejection in the Collaborative Corneal Transplantation StudiesOphthalmology, 1994
- Role of Lasers in Eye CareOptometry and Vision Science, 1993